Owner Agensys, Inc.

Inventors Morrison, Karen; Raitano, Arthur B.; Hubert, Rene S.; Faris, Mary; Jakobovits, Aya; Morrison, Robert Kendall; Ge, Wangmao; Challita-eid, Pia M.

Agent FB Rice

Pub. Number AU-B-2002318112

PCT Number PCT/US02/11654

PCT Pub. Number WO2002/083921

Priority 60/283,112 10.04.01 US; 60/286,630 25.04.01 US; 60/282,739 10.04.01 US

Filing date 10 April 2002

Wipo publication date 28 October 2002

Acceptance publication date 6 December 2007

C12N 5/12 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Fused cells, e.g. hybridomas

A01K 67/00 (2006.01) Rearing or breeding animals, not otherwise provided for

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

A61K 31/7088 (2006.01) - Compounds having three or more nucleosides or nucleotides

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61K 38/46 (2006.01) Medicinal preparations containing peptides

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 35/00 (2006.01) Antineoplastic agents

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 5/00 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 14/00 (2006.01) Peptides having more than 20 amino acids

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12Q 1/00 (2006.01) Measuring or testing processes involving enzymes or micro-organisms

C12Q 1/02 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay